![B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients](https://mma.prnewswire.com/media/1154691/double_stack_B_Braun_Medical_Inc.jpg?p=facebook)
B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients
![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb® B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://mma.prnewswire.com/media/1447289/B_Braun_OMNI.jpg?p=facebook)
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
![B. Braun Medical Oy on luottanut Accountorin monipuolisiin HR-palveluihin jo yli 10 vuotta | Accountor B. Braun Medical Oy on luottanut Accountorin monipuolisiin HR-palveluihin jo yli 10 vuotta | Accountor](https://www.accountor.com/sites/default/files/media/images/Mia%20Eklund%20800x800.jpg)
B. Braun Medical Oy on luottanut Accountorin monipuolisiin HR-palveluihin jo yli 10 vuotta | Accountor
![B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients - G-MedTech News Center B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients - G-MedTech News Center](https://www.g-medtech.com/news/wp-content/uploads/2020/04/20200415c-800x445.jpg)